NCT00540579 CC-4047 With Gemcitabine for Untreated Advanced Carcinoma of the Pancreas Status COMPLETED Phase PHASE1/PHASE2
NCT00537511 A Phase I/II Study to Determine the Maximum Tolerated Dose (MTD) and Safety of CC-4047 (Pomalidomide) Administered in Conjunction With Cisplatin and Etoposide Status TERMINATED Phase PHASE1/PHASE2
NCT00463385 A Phase II Study of Pomalidomide in Myelofibrosis With Myeloid Metaplasia Status COMPLETED Phase PHASE2